Location: Home
  • search
  • go
  • Relate News
  • 6/11/2018WuXi Biologics to Build a $60M Biologics Facility in the U.S.
  • 6/10/2018Will China's Promise to Boost Imports Benefit MNC Pharma Companies?
  • 6/8/2018Oncologie Commences Operations in Boston and Shanghai
  • 6/8/2018NMPA Issues 2017 Drug Inspection Report
  • 6/8/2018Recent Executive Moves
  • 6/8/2018Novo Nordisk Still Has Ample Room for Growth in China
  • 6/7/2018CNDA Suspends Import of Ambroxol Hydrochloride from India's Shilpa Med...
  • 6/7/2018CNDA Solicits Comments on 2nd Draft of the GMP Appendices for Narcotic...
  • 6/6/2018Hua Medicine Becomes Second Firm to Seek Hong Kong IPO under New Rules
  • 6/6/2018Guangdong Drug Regulator Sentenced Eight Years for Corruption
  • 6/6/2018CNDA Issues New Announcement (2018#30) for Clinical Data Self-Inspecti...
  • 6/6/2018Shanghai Bans Hospital Pharmacy Contract Management by Pharma Companie...
  • 6/6/2018CDE Solicits Feedbacks on Draft Dossier Requirements for Registration ...
  • 6/6/2018Chinese Military Adds 513 Drugs to Its Rationalized Medicine Drug List
  • 6/6/2018China Approves Indigenously-developed Long-acting Anti-HIV Drug
  • 6/5/2018Wize Pharma Signs China Distribution Deal for Dry Eye Drug LO2A
  • 6/5/2018The PD-1/PD-L1 Race in China
  • 6/5/2018MNC Pharma Cos Face Uncertainties of Chinese Data Transfer Rules
  • 6/5/2018NHC Issues Working Procedures for Developing the Rare Disease List
  • 6/5/2018CNDA Issues Notice to Strengthen Drug and Medical Device Regulation du...
  • 6/5/2018Xynmic Pharma Completes Series B Financing As It Opens R&D Cen...
  • 6/5/2018China Moves Closer to National Health Care Network with a New Data Cen...
  • 6/5/2018The Wistar Institute and Harbour BioMed Join Forces to Advance Novel A...
  • 6/5/2018Denovo Licenses Stanford's DB102 for Pulmonary Arterial Hypertension
  • 6/5/2018Chi-Med Cancer Trial Shows Clinically Meaningful Benefits
  • 6/5/2018Sinobioway Biomedicine to Invest Nearly $500M in Massive Biologics Sit...
  • 6/5/2018Walgreens Boots Alliance Completes Stake Reduction in Guangzhou Pharma
  • 6/5/2018PharmaLetter: What Does China's Open Policy Mean to Pharma Multination...
  • 6/5/2018HUYA Bio Reports Latest Progress with Oncology Pipeline
  • 6/4/2018Harbin Pharma and GNC in Talks to Form Chinese Joint Venture
  • Page:336/789 Total number of articles:23668: [First][<<] [334] [335] [336] [337] [338] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group